Schedule 13G ownership disclosure
VIRAX BIOLABS GROUP LTD
Ordinary Shares · CUSIP: G9495L125
Event date: 2023-12-31
- Filing-level shares
- 287,987
- Percent of class
- 12.9%
- James Foster
Shares: 287,987 · Class: 12.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-256646
- Form type
- SCHEDULE 13G/A
- Filer
- Foster James Alexander Cunliffe
- CIK
- CIK 1988784
- Filed
- Oct 29, 2025
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership